THIS WEBSITE IS INTENDED FOR SOUTH AFRICAN RESIDENTS ONLY
banner1

Contact Us

Product and Sanofi Details

S1 BUSCOPAN® 10 mg tablets. Each tablet contains hyoscine
butylbromide 10 mg. Ref. No. E 501 (Act 101/1965)


S1 BUSCOPAN® 0,1 % syrup. Each 5 ml of syrup contains
5 mg of hyoscine butylbromide. Reg. No. Z/11.2/93


For full prescribing information refer to the professional information
approved by the Regulatory Authority.


Applicant: sanofi-aventis south africa (pty) ltd,
Reg. no.: 1996/010381/07.
Sanofi House, 2 Bond Street, Grand Central Ext. 1, Midrand, 1685.

Tel: (011) 256 3700
Fax: (011) 256 3707.

www.sanofi.com

Contact Us

Side Effects/Safety:
za.Drugsafety@sanofi.com

Medical Queries:
ZA.CHCenquiries@sanofi.com

Product Quality Complaints:
za.productqualitycomplaints@sanofi.com

The website uses cookies to track its audience and improve its content.
By continuing to browse this website, you agree to the use of such cookies. Click here for more information on cookies.

ok